Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_assertion type Assertion NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_head.
- NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_provenance.
- NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_assertion evidence source_evidence_literature NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_provenance.
- NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_assertion SIO_000772 22491195 NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_provenance.
- NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_assertion wasDerivedFrom befree-20150227 NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_provenance.
- NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_assertion wasGeneratedBy ECO_0000203 NP541620.RAwuLEThua8fgJy2F8hx_68NBAqoBeZiYF4xaZlF4lvbo130_provenance.